The Registry of Oncology Outcomes Associated With Testing and Treatment
Public ClinicalTrials.gov record NCT04028479. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Registry of Oncology Outcomes Associated With Testing and Treatment (ROOT)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is to collect and validate regulatory-grade real-world data (RWD) in oncology using the novel, Master Observational Trial construct. This data can be then used in real-world evidence (RWE) generation. It will also create reusable infrastructure to allow creation or affiliation with many additional RWD/RWE efforts both prospective and retrospective in nature.
Study identification
- NCT ID
- NCT04028479
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 167 participants
Conditions and interventions
Conditions
- Adenocarcinoma
- Adenocystic Carcinoma
- Anal Cancer
- Appendix Cancer
- Brain Tumor
- Glioblastoma
- Astrocytoma
- Bile Duct Cancer
- Cholangiocarcinoma
- Bladder Cancer
- Bone Cancer
- Synovial Sarcoma
- Chondrosarcoma
- Liposarcoma
- Sarcoma, Kaposi
- Sarcoma,Soft Tissue
- Sarcoma
- Osteosarcoma
- CNS Cancer
- Brain Stem Neoplasms
- Breast Cancer
- Cervical Cancer
- Colorectal Cancer
- Rectal Cancer
- Colon Cancer
- Esophageal Cancer
- Esophagus Cancer
- Cancer of Colon
- Pancreatic Cancer
- Cancer of Pancreas
- Testis Cancer
- Testicular Cancer
- Ureter Cancer
- Renal Cell Carcinoma
- Kidney Cancer
- Gestational Trophoblastic Tumor
- Head and Neck Neoplasms
- Parotid Tumor
- Larynx Cancer
- Tongue Cancer
- Pharynx Cancer
- Salivary Gland Cancer
- Acute Myeloid Leukemia
- Chronic Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Multiple Myeloma
- Non Hodgkin Lymphoma
- Carcinoid Tumor
- Lung Cancer
- Neuroendocrine Tumors
- Mesothelioma
- Thyroid Cancer
- Parathyroid Neoplasms
- Adrenal Cancer
- Small Bowel Cancer
- Stomach Cancer
- Liver Cancer
- Hepatic Cancer
- Melanoma
- Skin Cancer
- Unknown Primary Tumors
- Uterine Cancer
- Fallopian Tube Cancer
- Ovarian Cancer
- Prostate Cancer
- Vaginal Cancer
- Penile Cancer
- Vulvar Cancer
- Waldenstrom Macroglobulinemia
- Cancer, Advanced
- Thymus Cancer
- Nasopharyngeal Carcinoma
- Multiple Endocrine Neoplasia
- Pheochromocytoma
- Small Cell Carcinoma
- Pulmonary Carcinoma
Interventions
- Biomarker Testing (L) Diagnostic Test
- Systemic Treatment (T) Drug
- Patient Reported Outcomes (P) Other
Diagnostic Test · Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 4, 2021
- Primary completion
- Oct 30, 2024
- Completion
- Oct 30, 2024
- Last update posted
- Dec 17, 2024
2021 – 2024
United States locations
- U.S. sites
- 2
- U.S. states
- 2
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teton Cancer Institute | Idaho Falls | Idaho | 83404 | — |
| Oncology and Hematology of South Texas | Laredo | Texas | 78041 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04028479, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 17, 2024 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04028479 live on ClinicalTrials.gov.